Protein Signals - Week of June 29, 2026

Deep Dive - Danone to Acquire Saputo's Australian Dairy Stake and Buy Protein Maker Made Group

The French nutrition group is consolidating full control of its Australian fresh-dairy JV and adding a high-protein beverage brand, deepening its tilt toward functional dairy. Buying out Saputo's 49% removes a partner from brands including YoPRO and Activia, while Made adds higher-growth protein revenue, valued near US$1.4 billion against roughly €300 million in sales. The paired deals extend the "Renew" playbook seen in the Huel and Kate Farms purchases, pressuring Lactalis and Fonterra to defend Asia-Pacific shelf space as Saputo exits the region.

The first sustained domestic screwworm detections since mid-century eradication move the US cattle complex from a demand story to a supply-access one. Mexico's suspension of US live-animal imports removes a primary outlet as the herd sits at a 75-year low, compounding drought scarcity and extending packer pricing power at Tyson and JBS. APHIS is scaling sterile-fly output toward 500 million weekly, but full capacity arrives only in 2029, leaving quarantine and treatment spend as the binding near-term burden and a recurring lane for parasiticide suppliers.

USDA's quarterly count shows the breeding base shrinking to 5.88 million head, with farrowing intentions down 2 percent through August, signaling a tighter forward supply of market hogs. Record productivity of 11.87 pigs weaned per litter blunts the headcount decline, so pork output contracts more slowly than the herd and preserves slaughter throughput even as live-hog costs firm. Iowa's 24.7-million-head share concentrates both supply and disease exposure, leaving 2026-27 packer margins dependent on whether litter-efficiency gains continue to offset a structurally smaller breeding base.

aXichem, a Nasdaq First North-listed Swedish developer of natural capsaicin-analogue feed additives, booked a call-off through distributor Chr. Olesen that completes, and slightly exceeds, a supply agreement framed in 2025. The repeat volume signals movement from trial to scaled uptake in the world's largest poultry exporter and validates phenylcapsaicin as a natural substitute for antibiotic growth promoters. Its push into the better-margin ruminant segment widens the addressable market beyond poultry, but the order's small size keeps aXichem an adoption watch-item, not an earnings driver.

The proposed terms would bind Cal-Maine alongside privately held rivals Hickman's Egg Ranch and Versova, among the largest US shell-egg producers, to abandon an industry price-benchmarking service. The few-million-dollar penalties and 50-million-egg donation are immaterial against the windfall margins layers captured during avian-influenza shortages, making the information-exchange prohibition the binding cost. That conduct remedy strips a coordination channel from a concentrated supply chain and sets a template for the bipartisan state attorneys general, while leaving the larger class-action exposure unresolved.